ARCHIVES

ASCO’s Lichter Says. Dingell, Stupak Urge FDA To “Act With Due Haste To Avoid Endangering Patients” Steered To ESAs.

This article is from The Cancer Letter archive.

Vol. 34 No. 09 | March 7, 2008

Download PDF Visit The Full Archive

Related Articles

In Brief: FDA Oncology Div. Director Burke To Leave; Reed Is Branch Chief; NCAB Blasts Tobacco

November 4, 1994

Three-Quarters of P01 $$ Goes To Translational Grants, NCI Finds

October 2, 1992

Acceptance Of Sentinel Node Biopsy Is Growing, Study Finds

October 31, 2003

Senate Committee Investigating Pharma’s “Educational Grants.”

January 20, 2006

In Brief: House, Senate Enact FY ’92 Budget Bills For NCI That Differ By $200 Million; Senate’s Is Higher

September 27, 1991

Foundation Gives $1 Million To UPCI For Genetics Chair

December 13, 2002